The Prediction Markets

Market comparison

Will the FDA approve retatrutide?

1 venue · 5 outcome rows · 0 comparable lines · 0 verified parity · active

Kalshi

Open venue ↗

5 outcomes · $70K reported volume

Observed 22s ago

Recorded venue end date: Jan 1, 2029

Check settlement rules before comparing contracts. Matched outcomes may settle differently. These are stored prices; record update times do not certify live quotes. Differences exclude fees and available size.

No shared outcome identities or comparable outcome lines are available for this event. Each venue’s outcomes are listed separately.

Before Jan 1, 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

4.0%

Bid 3.0% · Ask 4.0%

Before Jan 1, 2027

Open Kalshi ↗

Before Jan 1, 2028

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

70.0%

Bid 70.0% · Ask 71.0%

Before Jan 1, 2028

Open Kalshi ↗

Before Jan 1, 2029

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

90.0%

Bid 89.0% · Ask 90.0%

Before Jan 1, 2029

Open Kalshi ↗

Before Jul 1, 2027

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

18.0%

Bid 17.0% · Ask 18.0%

Before Jul 1, 2027

Open Kalshi ↗

Before Jul 1, 2028

Not aligned

No persisted outcome identity connects these venue contracts.

Kalshi

85.0%

Bid 84.0% · Ask 85.0%

Before Jul 1, 2028

Open Kalshi ↗

Prices are shown as percentages of a $1 payout. “pp” means percentage points. A dash means data is unavailable.

View event details, charts and rules →Explore more markets